GENE ONLINE|News &
Opinion
Blog

Feature
Trials & Approvals FDA Approval
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Special RNA Editing
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
2021-09-05
IPO Nanopore Sequencing
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
COVID-19 DNA Vaccine
Why Are Human DNA Vaccines Such a Big Deal?
2021-09-02
Trials & Approvals Schizophrenia
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
Trials & Approvals HIV
J&J’s HIV Vaccine Results Disappoint, Trial Halted But Search Continues
2021-09-01
Trials & Approvals Aduhelm
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
IPO SPAC
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
Trials & Approvals Prostate Cancer
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Funding
Laronde Bags $440 M in Series B to Advance Novel Medicines Using endless RNA Technology
2021-08-30
Deals Electronic Medical Record
Foundation Medicine Enters Partnership With Epic to Integrate Genomic Insights into EMR Systems
2021-08-30
Technology Targeted Protein Degrader
Eli Lilly, Lycia Partnership Signifies the Growing Targeted Protein Degradation Market
2021-08-27
Patent Infringement
Gilead’s Kite Wins Legal Battle Against BMS, Gets Its $1.2B Fine Overturned
2021-08-27
Interviews RNA Editing
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
1 … 30 31 32 33 34 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top